- States ranked by share of healthcare workers
- CMS finalizes framework for Medicaid work rules: 8 things to know
- Ochsner exec joins UMC New Orleans as COO
- Boston Children’s saves $7M, 60K hours with OpenAI
- From Calls to Clicks: Where Patient Experience Meets Throughput
- Maternal mental health grades by state
- 6 unique Rural Health Transformation fund proposals
- Illinois hospital taps CFO
- UHS Texas hospital taps new CFO
- Student debt rewrites oral surgery succession plans
- Health systems aren’t just killing more AI projects — they’re starting fewer
- Centerstone begins CEO transition
- 720 hospitals at risk of closure, by state
- Nonprofit opens dental center in Maine with $2M in funding
- 16 new behavioral health study findings to know
- AdventHealth relocates cardiology practice in Georgia
- Anesthesia under fire: 3 recent legal, policy fights
- Former lab CEO, physician to pay $1.2M+ to settle kickback scheme allegations
- MDMA-assisted therapy, explained
- PDS Health continues de novo growth with 5 new practices
- Commission Statement on the Passing of Former General Counsel David Becker
- 5 highest-paying states for specialty dentists
- Virginia oral surgery center opens 6th office
- New York health system to shutter ASC amid declining patient volume
- North Carolina projects $1B autism therapy spending: 6 notes
- 3 dental leadership moves to know
- CMS outlines national framework to support rollout of Medicaid work requirements
- The rise of the physician side hustle
- How NYU Langone is helping modernize a decades-old GI surgery tool
- The 6 highest-paying practice settings for ophthalmologists
- Dentists’ pay dipped the most in these 10 states
- Where the largest DSOs stand halfway through 2026
- ASCA elects new board president
- 7 physician practices shut their doors in 1 month
- Physician groups welcome IDR rule changes
- Indiana dental office suffers data breach affecting 5,900 individuals
- Your Surprise Medical Bill May Be Gone — But Your Premiums Could Still Spike
- New Connecticut private equity law bans hospital sale-leasebacks
- 17 dentists making headlines
- Mental health ED visits on the rise in 2026: 5 things to know
- How 4 systems are breaking the ED boarding cycle
- CDC: 2025's uninsured rate stayed flat at 8.3%
- Trump signs off on HHS overhaul of childhood vaccine schedule with new executive order
- Trump signs off on HHS overhaul of childhood vaccine schedule with new executive order
- Short-Term Fasting Could Boost Chemo Response in Ovarian Cancer, Study Suggests
- MedTech In Focus: AI impact in healthcare
- MedTech In Focus: AI impact in healthcare
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
- Patients with treatment-resistant depression are costing Medicare big
- Shionogi's COVID antiviral Xocova passes muster with FDA as post-exposure preventative
- How HER2 biology is shaping next-generation cancer treatment
- Workout Habits May Protect Against Inherited Heart Problems
- Childhood Lying Is Normal and Rarely Signals Behavioral Concerns, Study Says
- Perfectionism Among College Students Reaches Record High, Fueling Anxiety
- After Her Bout of Amnesia, A $59,000 Billing Dispute Wouldn't Go Away
- Weed Linked To Higher Testosterone Levels In Young Men
- Amid Ebola, Hantavirus Outbreaks, Democrats Decry Trump’s Health Cuts
- Baffling. Frustrating. Frightening. What It’s Like To Be Sued Over Medical Debt.
- Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight
- ViiV Healthcare launches ‘PrEP Wisdom’ campaign to boost awareness of long-acting HIV prevention meds
- Noom launches at-home biomarker test kit for metabolic health monitoring
- ASCO: AstraZeneca's Imfinzi, Imjudo duo shines in earlier-stage liver cancer
- CVS, Walgreens and Walmart defeat opioid lawsuit brought by Florida hospitals
- ASCO: Sac-TMT’s massive phase 3 program has a jarring gap. Does Merck plan to close it?
- ASCO: Akeso’s ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34%
- ASCO: J&J breaks the prostate cancer treatment mold with fresh Erleada ph. 3 win
- ASCO: Revolution Medicines confident in RAS leadership as rivals square up
- Contraception For Teens: Let's Talk About It
- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win
- ASCO: Lilly ties Retevmo to ‘dramatic’ outcomes in early-stage lung cancer with rare RET biomarker
- ASCO: With bispecifics on its heels, Incyte positions Monjuvi combo for first-line DLBCL
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- Enzo Health launches agentic EHR for home health agencies
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Listen to the Latest ‘KFF Health News Minute’
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- Why direct-to-patient is the future of pharma access
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- Cleveland Clinic, Aspira Women’s Health partner on AI-powered women's health diagnostics
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Remarks at the Stanford Rock Center for Corporate Governance
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
The Bureau of Labor Statistics (BLS) has been peddling the fiction that health insurance costs have been declining since the onset of COVID-19. This fiction has warped the entire Consumer Price Index, the most followed gauge of inflation in our economy. Inflation is running several percent higher than reported in the CPI due to several creative BLS fictions. Using the pre corruption methodologies of the 1970's, actual CPI is at least double that reported by BLS.
BLS will make minor changes to their calculation of the health insurance cost index in tomorrow's CPI report because absolutely no one believed their lies about health insurance costs. The new calculation will show sub 1% monthly increases in health care insurance costs. Still a lie, just a less egregious lie:
Health Insurance Is About To Boost Inflation After Months Of Relief
Molly Smith • November 13, 2023A change in how the government estimates health insurance costs is expected to give a slight boost to a popular US inflation measure, reversing a trend that had been providing some relief in recent months.
Beginning with Tuesday’s release of the October consumer price index, the Bureau of Labor Statistics will roll out a few changes to how it tabulates the category. In addition to a routine change in source data, the new methodology will aim to smooth some of the volatility and reduce time lags in the index.
After being a reliable drag on overall inflation for the past year, the new computation is widely anticipated to put upward pressure on the headline CPI, at least in the near term. It’ll also boost a narrower subset of services inflation that excludes energy and housing.
The Federal Reserve monitors so-called core services closely, but computes it based on separate price index figures within the personal consumption expenditures and income report.
“We think the Federal Reserve will continue to look past these shifts in health insurance CPI, as these estimates do not factor into the construction of the PCE price index, the Fed’s preferred inflation gauge,” Barclays Plc economists led by Pooja Sriram said in a report. That metric “is much more comprehensive than the retained-earnings concept used in the CPI,” they said.
Since health insurance policies and premiums vary widely, the BLS computes the cost through an indirect method. Essentially, it reflects the business cost of offering consumers health insurance, whereas services for seeing a doctor or a hospital stay are calculated separately and are at or near record-high price levels.
The health insurance index, by contrast, is currently at its lowest reading in nearly six years. But what Americans actually pay for coverage is a different story.
US employers expect the total benefit cost per employee to rise 5.4% on average next year — even after they make changes to their plans to slow cost growth — according to a preliminary survey from workplace consultant Mercer. Other polls have found that nearly 40% of Americans have had to forgo healthcare because they couldn’t afford it.
The CPI index of health insurance measures what customers pay into their policy that’s not distributed out in benefits — also known as an insurer’s retained earnings, or profit margins. The BLS currently receives this data annually, but is switching to a semiannual update to reduce lags in the index.
For the past year, the health insurance category has fallen at a roughly 4% clip each month. Bloomberg Economics and Bank of America Corp. expect the changes to result in CPI health insurance rising roughly 1% starting in the October report. Barclays sees that pace lasting through March 2024 once the BLS incorporates the semiannual data, while Goldman Sachs Group Inc. expects the category to slow to a flat reading by April.
The BLS doublespeak on their health care index 'improvements':
https://www.bls.gov/cpi/additional-resources/improvements-cpi-health-insurance-index.htm
Improvements to the CPI Health Insurance Index
CORRECTION TO THIS PAGE MADE AUGUST 23, 2023
When this webpage was first published on 08/22/2023 the equation for the TTM sequential relative was incorrectly shown as a duplicate of the equation for the TTM retained earnings ratio.
Introduction
BLS will implement changes to the Consumer Price Index (CPI) health insurance methodology starting with the calculation of October 2023 indexes. The pre-October 2023 method is based on an annual calculation using aggregated health insurance premium and benefit data. Two concerns with the pre-October 2023 methodology are the volatility in the annual data and the lag involved in incorporating the health insurance financial data. To address these concerns, we are introducing smoothing to the index to reduce the volatility. We will also incorporate semiannual financial data, which reduces the lag in the index.
After providing an overview of the health insurance data and pre-October 2023 methodology, we discuss the recommendations that led to the changes in the methodology. Then, we discuss the new methodology that uses a smoothed semiannual index instead of an unsmoothed annual index. Finally, there are issues relating to the transition which require adjustments to correct.
CPI health insurance methodology
The CPI measures health insurance inflation using an indirect method.[1] The indirect method views health insurance as a composite good. Total premiums pay for insurance services (risk protection, claim processing, etc.) and medical goods and services through the insurer reimbursements to providers. Rather than pricing the full premium of health insurance plans, the CPI prices the services provided by the health insurer measured by the portion of the total premium that isn’t used to indirectly purchase medical goods and services. The premiums minus benefits spending is known as the retained earnings.
Then, the measured prices of medical goods and non-insurance services (e.g., physicians, hospitals, etc.) are defined to be the total reimbursed amount and include any payments from insurers. The associated out of pocket expenditure weights are reassigned from premiums to the medical goods and non-insurance services categories. So, the only weight remaining to the health insurance index reflects the retained earnings.[2] Since the insurance spending on medical benefits is included in the non-insurance medical indexes, the insurance services price should not include the impact of benefit inflation on total premiums. Instead, BLS defines the price of these insurance services as the ratio of retained earnings (premiums minus benefits) and real benefits (benefits adjusted for medical inflation).
Prior to October 2023, the health insurance premium and benefits data used in the calculation of the health insurance price relative are annual. The CPI health insurance monthly relative is the twelfth root of the year over year change in the retained earnings to benefit ratio times medical benefits inflation. There are two retained earnings relatives. The first covers most health plans and reflects most of the weight of the index. The second covers plans not included in the first calculation, specifically long-term care (LTC) insurance and Medicare Part D.
Despite some practical advantages of the indirect method, there are some limitations. First, the retained earnings ratio can be volatile, which can cause the retained earnings relative to fluctuate substantially from one year to the next. The reason for this volatility is that insurance plans cover a full year, so premiums are only updated once a year, and utilization within the year can be unpredictable. If utilization is unexpectedly high in a given year, the retained earnings to benefits ratio will fall. The next year, insurers will raise premiums to rebuild their reserves, and the retained earnings to benefits ratio will rise.
Another limitation is that the data are lagged. The health insurance index does not reflect contemporaneous retained earnings information since there is a lag in the availability of the retained earnings data to the CPI. The primary data source for the retained earnings relative in the CPI health insurance index is the U.S. Health Insurance Industry Analysis Report published by the National Association of Insurance Commissioners (NAIC) on an annual basis. The main health insurance relative combines this data with data from California as managed care plans in California report to a different regulator. The second retained earnings relative that covers long term care (LTC) and Medicare part D uses data from the NAIC Accident and Health Policy Experience Report.
CNSTAT report and recommendations
The BLS recently asked the National Academies of Science, Engineering, and Medicine, Committee on National Statistics (CNSTAT) for recommendations on improving the CPI, including recommendations on pricing health insurance. The final CNSTAT report was released in 2022.[3] CNSTAT recommended that the BLS continue to use the indirect method for pricing health insurance (recommendation 5.1) but made several recommendations for how the indirect method could be improved.
Smoothing
One issue with the pre-October 2023 method is there can be a lot of volatility in the retained earnings data from one year to the next. There is a question as to whether smoothing the retained earnings data using a moving average is desirable when calculating the relative. This section discusses the arguments for and against smoothing the annual retained earnings data.
The argument against smoothing is that the volatility represents real price changes that should be reflected in the index. If consumers on average have unexpectedly high utilization in a given year, they are receiving a benefit from having their premium locked in for the year. In terms of the insurance services, they are paying less for them (lower retained earnings) and getting more out of them (assuming the quantity of insurance services is proportional to utilization), which means that the price of insurance services has fallen. If this is considered a real price change, then it is irrelevant that it will likely be reversed in the following year. It can be viewed analogously to a sale, with consumers benefitting from prices that are lowered temporarily.
The argument for smoothing is that the relevant price when considering insurance is the ex-ante price.[4] Any ex-post deviations from expected utilization should not be considered real price changes. Individuals can be viewed as facing a fixed price schedule with uncertain utilization. The actual realized retained earnings to benefits ratio will depend on utilization and can show a change in price even if the price schedule is fixed. In similar situations where the price depends on total utilization, the CPI will hold utilization constant when pricing (for example, in the pricing of electricity). CNSTAT argued that the ex-ante price is the relevant price and suggested we consider smoothing (recommendation 5.3). We agree with CNSTAT that the ex-ante price is the more appropriate measure, so a relative calculated from smoothed retained earnings data will be a more accurate measure of price change. A limitation of smoothing is that if the retained earnings to benefit ratio changes for ex-ante reasons (reflecting a real ex-ante price change), smoothing will delay the impact of this change on the price index.
Incorporating retained earnings data sooner
Pre-October 2023, the annual retained earnings data is incorporated into the CPI starting in October after the calendar year for the retained earnings data. For example, in October 2022, retained earnings data was first incorporated into the index reflecting the change in the retained earnings to benefits ratio from 2020 to 2021. This annual change is smoothed over 12 months, so the 2021 retained earnings data will not be fully reflected in the index until September 2023.
Exploring the use of quarterly data to improve the timeliness of the index was another recommendation of the CNSTAT panel (recommendation 5.6).
Proposed changes to the CPI health insurance index
After conducting extensive research on these recommendations, we determined that the health insurance index could be improved by smoothing the retained earnings data and by using more timely, higher frequency data. In this section, we summarize how we plan to implement these changes to the methodology.
Smoothing the Retained Earnings Data
Following the recommendation to smooth the retained earnings data, we investigated different window lengths for the moving average and considered simple versus exponential moving averages. Ultimately, we chose to smooth using a 2-year simple moving average of the retained earnings ratio. Unusual deviations in the retained earnings are generally reversed the following year, so a 2-year average is sufficient for smoothing. Using additional years has less of an impact on smoothing and introduces unnecessary lag. We also favor using a simple moving average versus an exponential moving average as the exponential moving average will retain more of these 1-year deviations. The smoothing will be applied to both retained earnings calculations.
Semiannual updates
Overall, semiannual and quarterly updates are feasible and improve the timeliness of the index (by six months for semiannual updates and nine months for quarterly updates). A limitation of the quarterly updates is that the data is not provided at the level of detail that allows us to exclude out-of-scope plans. So out-of-scope plans are included in the calculation to impute quarterly changes in the in-scope retained earnings. The quarterly updating can increase volatility, and there is no way to know whether this volatility is driven by in-scope plans (reflecting a true price change that we would want to show in the index) or out-of-scope plans.
Updating twice a year is a clear improvement over the annual method and improves the timeliness of the index by six months compared to the annual updates. The additional benefit of improved timeliness (3 months) of updating quarterly is offset by an increase in volatility. At this time, we decided to switch to semiannual updates as it is not clear the added timeliness of updating quarterly is worth the increase in volatility. However, we will continue to research quarterly data and may incorporate it in the indexes at some point in the future. The semiannual updates will apply to the main retained earnings calculation. The second retained earnings calculation, covering LTC and Medicare part D, will continue to update annually in October, though we will continue to explore options for imputing the semiannual changes for this data.
Computation of semiannual updates
In terms of implementing the semiannual updates, the mid-year report includes data through June 30, and the final report includes the full year data. To calculate the 2nd half data, we subtract the mid-year report values from the full year data. Once we have the data by half, there are several options for creating semiannual relatives. The formula we chose to incorporate the semiannual updates is a sequential trailing 12 month relative of the retained earnings to benefit ratio. One issue is that the NAIC data are not complete and must be supplemented with data from managed care plans in California that report to a different regulator. The California data are not available at the necessary level of detail semiannually, so we impute the first half of California data using changes in the NAIC data.
The trailing 12 month (TTM) index pools two halves of data and calculates the sequential relative. Once the second half of the year data is incorporated, the TTM and full year indexes will be identical. This is a desirable property of the TTM index as it will equal the full year index once each index incorporates the same data. For this reason, the TTM index is our preferred method as it will automatically correct any errors in the first half data, whether due to data reporting issues or imputation error relating to the California data. The main advantage of the semiannual index is that it will incorporate this change six months sooner than the annual index. The TTM retained earnings to benefit ratio in half H is:
The TTM sequential relative is:
Incorporating both changes, the TTM smoothed relative in half H is:
This is a semiannual relative, so the monthly retained earnings relative is calculated by taking the sixth root. The monthly retained earnings relative is:
The monthly retained earnings relative is multiplied by the relatives for medical benefits to form the health insurance relative. This is the calculation for the semiannual updates starting in April 2024 that will incorporate the first half of 2023 data. To switch from an unsmoothed annual index to a smoothed semiannual index, adjustments must be made to the October 2023 update that incorporates the 2022 annual data. We discuss the adjustments for this transition period in the next section.
Transition
Both methodological changes (smoothing retained earnings and incorporating retained earnings data sooner) introduce issues with the transition from pre-October 2023 methods. The first issue relates to the timing of the semiannual and annual indexes. Since, the semiannual index is six months ahead of the annual index, switching from annual to semiannual requires speeding up the next annual update. Instead of spreading the 2022 annual update over 12 months, it would be spread over six months by taking the sixth root instead of the twelfth root. Then, in April 2024, we would be able to update the indexes with 2023 first half retained earnings data since the 2022 data will be fully reflected in the index.
The second issue is that, unless a correction term is applied, switching from an unsmoothed to a smoothed relative will create a permanent distortion in the index. See the technical appendix on smoothing retained earnings for an example that illustrates how this distortion arises and how we derive the corrected relative.
Summary
Following recommendations from CNSTAT, starting in April 2024, we will switch the retained earnings calculation from an annual relative updated in October to a two year moving average using semiannual data and will update in April and October.[5] The next annual update in October 2023 will involve a six month transition to account for issues relating to changing in methodology. Table 1 provides a summary of the update timing moving forward.
Table 1: Summary of future updates to the CPI health insurance index Index Month Summary of update October 2023
Incorporate 2022 annual retained earnings data as an adjusted smoothed relative. For the main RE calculation, this update will be spread over six months. For the LTC/Part D calculation, it will be spread over a year. See the technical appendix for the derivation of the adjustment term. April 2024
Update the main RE calculation to incorporate the first half data for 2023. The update will be the semiannual sequential smoothed relative and smoothed over six months. The contribution of California managed care plans to the first half of 2023 retained earnings and benefits will be imputed from changes in the NAIC data. October 2024
Annual update to incorporate full year 2023 data. Second half of 2023 values are calculated by subtracting the first half totals (or first half imputed values for CA managed care plans). For the main RE calculation, the second half data is incorporated as the semiannual sequential TTM smoothed relative and smoothed over the following six months. For the LTC/part D retained earnings calculation, full year 2023 values are incorporated as a smoothed annual relative which is spread over the following 12 months. April/October
In future years, the April/October update process will continue. First half data will be incorporated in April and the full year update will occur in October. Note: This is the tentative schedule for the proposed methodology changes. BLS may amend this schedule in the future as we learn from experience.
Details regarding the transition to this new methodology are provided in: Technical Appendix to Improvements to the CPI Health Insurance Index: Transitioning from an unsmoothed to a smoothed relative
Last Modified Date: August 30, 2023
[1] For more detail on the CPI health insurance methodology see the CPI medical care factsheet.
[2] An alternative to the indirect method would be to price total premiums. Then, the prices and weights of medical goods and non-insurance services would only include out of pocket payments.
[3] The final report can be found here. Chapter 5 focuses on improvements to the medical indexes, with particular emphasis on the pricing of health insurance.
[4] The ex-ante price refers to the insurers setting premiums before knowing what the utilization will be during year. The premium is set based on expected utilization. The benefits spending we observe is based on actual utilization (ex-post), which may differ from what the insurance company expected when setting the premium.
[5] Part of the index will still use annual data but will also switch to using a two year moving average.
The BLS October 2023 CPI report is now available:
https://www.bls.gov/news.release/pdf/cpi.pdf
Go to its Table 2, Page 15 and scroll down to Medical care services. BLS claims the costs of Medical care services declined by 2% from October 2022 to October 2023. BLS claims the costs of Health insurance, the bottom item in the Medical care services section, declined by 34% from October 2022 to October 2023.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.




















